Presented
by

Presented by Oxford Global

Member Login
|
Join Community

All Biologics Content

Bringing you the latest research in Proteins and Antibodies, Peptides, and Oligonucleotides through a range of Speaker Interviews, Industry Insights, and Expert Opinions.
Commentary
A New Cancer-Killing Bispecific Antibody Working Toward the Clinic in 2022
The joint development project by Alligator Bioscience and Aptevo Therapeutics, ALG.APV-527, shows potential in targeting solid tumours
By Tom Cohen |
17 January 2022
Bispecifics
Video Content
Video Q&A
In Conversation with… Peter Ellmark, Alligator Bioscience
Video Interview: Find out why Neo-X is so unique
22 February 2021
Bispecifics
Video Content
Video Q&A
In Conversation with... Bryan Glaser, Vice President, Invenra
Video Interview: Let's talk bispecific antibodies. 10 minutes with... Bryan Glaser, Vice President of Invenra
10 February 2021
Bispecifics
Video Content
Webinar
Bispecifics Discovery & Platform Development
Workshop Speakers Include: Christian Klein, Department Head Cancer Immunotherapy Discovery 3, Roche Innovation Center Zurich | Julian Andreev, Research Fellow, Regeneron | Marlon Hinner, Principal Scientist & Group Leader, Roche Innovation Centre Munich | Danielle Mandikan, Scientist, Genentech
07 July 2020
Bispecifics
Written Q&A
The Future of Therapeutic Antibodies
John Delaney, Director, Research Technologies and Collaborations, Amgen. Date of Congress: 27th - 29th April 2020
02 January 2020
Bispecifics
Video Content
Webinar
Bispecific Antibodies Targeting The Innate Immune Checkpoint CD47
Webinar on 'Bispecific Antibodies Targeting The Innate Immune Checkpoint CD47'Hosted by Nicolas Fischer, Chief Executive Officer, Light Chain Bioscience
02 January 2020
Bispecifics
Written Q&A
The Role of Bispecific Antibodies within the Healthcare Industry
Antonin De Fougerolles, Chief Executive Officer, Evox Therapeutics
11 June 2019
Bispecifics
Video Content
Webinar
Nanofitin-Antibody Fusion as a Novel Multispecific Platform: Providing Extra Specificities While Maintaining Developability
Mathieu Cinier, Scientific Director, Affilogic
11 June 2019
Bispecifics

Search by Keyword

Filter by Subject Area

Filter by Content Type

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Twitter Linkedin-in

Event Series

About

Careers

Legal

Copyright Oxford Global Marketing Limited. All rights reserved.

Member Community Login